Abstract
LEARNING OBJECTIVE:
- Apply guideline recommendations to identify patients with atrial fibrillation suitable for non–vitamin K oral anticoagulant (NOAC) therapy for the prevention of stroke
- Review practical considerations for the safe and effective use of NOACs in the primary care setting